MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹93 Cr | ₹21 Cr | ₹176 Cr | ₹94 Cr | ₹118 Cr |
What is the latest Net Cash Inflow / Outflow ratio of MARKSANS PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹93 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹176 Cr |
| Mar2022 | ₹94 Cr |
| Mar2021 | ₹118 Cr |
How is Net Cash Inflow / Outflow of MARKSANS PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹93 Cr | 343.90 | |
| Mar2024 | ₹21 Cr | -88.16 | |
| Mar2023 | ₹176 Cr | 86.52 | |
| Mar2022 | ₹94 Cr | -20.33 | |
| Mar2021 | ₹118 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹8,028.4 Cr | 7.8% | -2.9% | -27% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 7.8% |
-2.9% |
-27% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses